Michael Simanovsky - 11 Mar 2026 Form 4 Insider Report for SONIDA SENIOR LIVING, INC. (SNDA)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
13 Mar 2026, 19:54:44 UTC
Prior SEC filing
13 Jan 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
MICHAEL J. SIMANOVSKY by: /s/ Paul Dumaine, Attorney-in-fact for Michael J.Simanovsky

Key filing fact

Michael Simanovsky filed Form 4 for SONIDA SENIOR LIVING, INC. (SNDA) on 13 Mar 2026.

Key facts

  • This page summarizes Michael Simanovsky's Form 4 filing for SONIDA SENIOR LIVING, INC. (SNDA).
  • 16 reported transactions and 10 derivative rows are listed below.
  • Accepted by SEC: 13 Mar 2026, 19:54.

Change

  • Previous filing in this sequence was filed on 13 Jan 2025.
  • Current net transaction value: +$100,000,006.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (7)

CIK 0001596522 Primary reporting owner

Simanovsky Michael

Relationship
Director, 10%+ Owner
Address
25 DEFOREST AVENUE, 3RD FLOOR, SUMMIT
Signature
MICHAEL J. SIMANOVSKY by: /s/ Paul Dumaine, Attorney-in-fact for Michael J.Simanovsky
Signature date
13 Mar 2026
CIK 0001850901

Conversant Capital LLC

Relationship
Director, 10%+ Owner
Address
25 DEFOREST AVENUE, 3RD FLOOR, SUMMIT
Signature
CONVERSANT CAPITAL LLC by: /s/ Paul Dumaine, General Counsel and Chief Compliance Officer
Signature date
13 Mar 2026
CIK 0001850910

Conversant GP Holdings LLC

Relationship
Director, 10%+ Owner
Address
25 DEFOREST AVENUE,, 3RD FLOOR, SUMMIT
Signature
CONVERSANT GP HOLDINGS LLC by: Conversant GP Holdings LLC, its general partner by: /s/ Paul Dumaine, General Counsel and Chief Compliance Officer
Signature date
13 Mar 2026
CIK 0001892127

Conversant Dallas Parkway (A) LP

Relationship
Director, 10%+ Owner
Address
25 DEFOREST AVENUE, 3RD FLOOR, SUMMIT
Signature
CONVERSANT DALLAS PARKWAY (A) LP by: Conversant GP Holdings LLC, its general partner by: /s/ Paul Dumaine, General Counsel and Chief Compliance Officer
Signature date
13 Mar 2026
CIK 0001892128

Conversant Dallas Parkway (B) LP

Relationship
Director, 10%+ Owner
Address
25 DEFOREST AVENUE, 3RD FLOOR, SUMMIT
Signature
CONVERSANT DALLAS PARKWAY (B) LP by: Conversant GP Holdings LLC, its general partner by: /s/ Paul Dumaine, General Counsel and Chief Compliance Officer
Signature date
13 Mar 2026
CIK 0002034835

Conversant Private GP LLC

Relationship
Director, 10%+ Owner
Address
25 DEFOREST AVENUE, 3RD FLOOR, SUMMIT
Signature
CONVERSANT PRIVATE GP LLC by: /s/ Paul Dumaine, General Counsel and Chief Compliance Officer
Signature date
13 Mar 2026
CIK 0002034747

Conversant PIF Aggregator A, LP

Relationship
Director, 10%+ Owner
Address
25 DEFOREST AVENUE, 3RD FLOOR, SUMMIT
Signature
CONVERSANT PIF AGGREGATOR A LP by: Conversant Private GP LLC, its general partner by: /s/ Paul Dumaine, General Counsel and Chief Compliance Officer
Signature date
13 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SNDA transaction

Common Stock

Purchase

Transaction value
$42,580,936
Shares
+1,592,406
Change %
+99%
Price
$26.74
Shares after
3,199,998
Date
11 Mar 2026
Ownership
See footnotes
Footnotes
F1, F2, F3
SNDA transaction

Common Stock

Purchase

Transaction value
$2,340,552
Shares
+87,530
Change %
+1.7%
Price
$26.74
Shares after
5,353,689
Date
11 Mar 2026
Ownership
See footnotes
Footnotes
F1, F4, F5
SNDA transaction

Common Stock

Purchase

Transaction value
$6,011,927
Shares
+224,829
Change %
Price
$26.74
Shares after
224,829
Date
11 Mar 2026
Ownership
See footnotes
Footnotes
F3, F9
SNDA transaction

Common Stock

Purchase

Transaction value
$49,066,590
Shares
+1,834,951
Change %
Price
$26.74
Shares after
1,834,951
Date
11 Mar 2026
Ownership
See footnotes
Footnotes
F3, F10
SNDA transaction

Common Stock

Options Exercise

Transaction value
Shares
+1,504,134
Change %
+28%
Price
$32.00*
Shares after
6,857,823
Date
11 Mar 2026
Ownership
See footnotes
Footnotes
F4, F5
SNDA transaction

Common Stock

Options Exercise

Transaction value
Shares
+97,371
Change %
+14%
Price
$32.00*
Shares after
807,115
Date
11 Mar 2026
Ownership
See footnotes
Footnotes
F5, F6
SNDA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,032,216
Date
11 Mar 2026
Ownership
See footnotes
Footnotes
F5, F7
SNDA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
648,942
Date
11 Mar 2026
Ownership
See footnotes
Footnotes
F5, F8

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SNDA transaction Derivative

Series A Convertible Preferred Stock

Disposed to Issuer

Transaction value
Shares
+38,742
Change %
Price
Shares after
0
Date
11 Mar 2026
Ownership
See footnotes
Underlying class
Common Stock
Underlying amount
1,203,308
Exercise price
$40.00
Footnotes
F4, F5, F11, F12
SNDA transaction Derivative

Series A Convertible Preferred Stock

Disposed to Issuer

Transaction value
Shares
+2,508
Change %
Price
Shares after
0
Date
11 Mar 2026
Ownership
See footnotes
Underlying class
Common Stock
Underlying amount
77,897
Exercise price
$40.00
Footnotes
F5, F6, F11, F12
SNDA transaction Derivative

Series A Convertible Preferred Stock

Award

Transaction value
Shares
+38,742
Change %
Price
Shares after
38,742
Date
11 Mar 2026
Ownership
See footnotes
Underlying class
Common Stock
Underlying amount
1,504,134
Exercise price
$32.00
Footnotes
F4, F5, F11, F12
SNDA transaction Derivative

Series A Convertible Preferred Stock

Award

Transaction value
Shares
+2,508
Change %
Price
Shares after
2,508
Date
11 Mar 2026
Ownership
See footnotes
Underlying class
Common Stock
Underlying amount
97,371
Exercise price
$32.00
Footnotes
F5, F6, F11, F12
SNDA transaction Derivative

Series A Convertible Preferred Stock

Options Exercise

Transaction value
Shares
+38,742
Change %
Price
$0.000000*
Shares after
0
Date
11 Mar 2026
Ownership
See footnotes
Underlying class
Common Stock
Underlying amount
1,504,134
Exercise price
$32.00
Footnotes
F4, F5, F11
SNDA transaction Derivative

Series A Convertible Preferred Stock

Options Exercise

Transaction value
Shares
+2,508
Change %
Price
$0.000000*
Shares after
0
Date
11 Mar 2026
Ownership
See footnotes
Underlying class
Common Stock
Underlying amount
97,371
Exercise price
$32.00
Footnotes
F5, F6, F11
SNDA transaction Derivative

Warrant

Disposed to Issuer

Transaction value
Shares
+968,538
Change %
Price
Shares after
0
Date
11 Mar 2026
Ownership
See footnotes
Underlying class
Common Stock
Underlying amount
968,538
Exercise price
$40.00
Footnotes
F4, F5, F12
SNDA transaction Derivative

Warrant

Disposed to Issuer

Transaction value
Shares
+62,712
Change %
Price
Shares after
0
Date
11 Mar 2026
Ownership
See footnotes
Underlying class
Common Stock
Underlying amount
62,712
Exercise price
$40.00
Footnotes
F5, F6, F12
SNDA transaction Derivative

Warrant

Award

Transaction value
Shares
+968,538
Change %
Price
Shares after
968,538
Date
11 Mar 2026
Ownership
See footnotes
Underlying class
Common Stock
Underlying amount
968,538
Exercise price
$40.00
Footnotes
F4, F5, F12
SNDA transaction Derivative

Warrant

Award

Transaction value
Shares
+62,712
Change %
Price
Shares after
62,712
Date
11 Mar 2026
Ownership
See footnotes
Underlying class
Common Stock
Underlying amount
62,712
Exercise price
$40.00
Footnotes
F5, F6, F12
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 12 footnotes

Footnote F1

This Form 4 is being filed jointly by Michael Simanovsky, a United States citizen; Conversant Capital LLC, a Delaware limited liability company ("Conversant Capital"); Conversant GP Holdings LLC, a Delaware limited liability company ("Conversant GP"); Conversant Dallas Parkway (A) LP, a Delaware limited partnership ("Investor A"); Conversant Dallas Parkway (B) LP, a Delaware limited partnership ("Investor B"); Conversant Private GP LLC, a Delaware limited liability company ("Conversant Private GP") and Conversant PIF Aggregator A LP, a Delaware limited partnership ("Aggregator A") (collectively the filing persons are the "Reporting Persons").

Footnote F2

Securities are held by Aggregator A.

Footnote F3

Conversant Private GP is the general partner of Aggregator A, CPIF K Co-Invest SPT A, L.P., a Cayman Islands exempted limited partnership ("CPIF K") and CPIF Sparti SAF, L.P., a Delaware limited partnership ("CPIF SAF") and Conversant Capital is the investment manager to Aggregator A, CPIF K and CPIF SAF. Mr. Simanovsky is the managing member of Conversant Capital and Conversant Private GP. By virtue of these relationships, each of Mr. Simanovsky, Conversant Capital and Conversant Private GP may be deemed a beneficial owner of the securities held by Aggregator A, CPIF K and CPIF SAF. Mr. Simanovsky, Conversant Capital and Conversant Private GP, each disclaims beneficial ownership of the securities held by Aggregator A, CPIF K and CPIF SAF except to the extent of his or its pecuniary interest therein.

Footnote F4

Securities are held by Investor A.

Footnote F5

Conversant GP is the general partner of each of Investor A, Investor B, Conversant Dallas Parkway (D) LP, a Delaware limited partnership ("Investor D") and Conversant Dallas Parkway (F) LP, a Delaware limited partnership ("Investor F"). Conversant Capital is the investment manager to each of Investor A, Investor B, Investor D and Investor F. Mr. Simanovsky is the managing member of Conversant Capital and Conversant GP. By virtue of these relationships, each of Mr. Simanovsky, Conversant Capital and Conversant GP may be deemed a beneficial owner of the securities held by each of Investor A, Investor B, Investor D and Investor F. Mr. Simanovsky, Conversant Capital, and Conversant GP each disclaims beneficial ownership of the securities held by Investor A, Investor B, Investor D and Investor F except to the extent of his or its pecuniary interest therein.

Footnote F6

Securities are held by Investor B.

Footnote F7

Securities are held by Investor D.

Footnote F8

Securities are held by Investor F.

Footnote F9

Securities are held by CPIF K.

Footnote F10

Securities are held by CPIF SAF.

Footnote F11

There is no expiration date for the right of the holder of Series A Convertible Preferred Stock to convert.

Footnote F12

On March 11, 2026, the Issuer agreed with each of Investor A and Investor B to (i) amend the shares of Series A Convertible Preferred Stock to reduce the conversion price to $32 per share of Common Stock, (ii) make a onetime payment of approximately $5.8 million in the aggregate, which included approximately $1.1 million of accrued but unpaid dividends for the period of January 1, 2026 through March 11, 2026, to Investor A and Investor B pro rata in accordance with their holdings of Series A Convertible Preferred Stock, and (iii) extend the expiration of the Warrants by one year, from November 3, 2026 to November 3, 2027, and each of Investor A and Investor B agreed to immediately thereafter convert its shares of Series A Convertible Preferred Stock to shares of Common Stock.

SEC remarks

Michael Simanovsky, Conversant Capital's Managing Partner, and Robert T. Grove, a Principal of Conversant Capital, serve as members of the Issuer's board of directors. On the basis of the relationship between Messrs. Simanovsky and Grove and the Reporting Person, the Reporting Person may be considered a director of the Issuer for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .